Psychometric properties of the CAST and SDS scales in young adult cannabis users

Addictive Behaviors

Volumn 37, Issue 6, 2012, Pages 709-715

  Cuenca Royo, Aida M ^a,b   Sánchez Niubó, Albert ^a,b   Forero, Carlos G ^a,b   Torrens, Marta ^c,d   Suelves, Josep M ^e   Domingo Salvany, Antònia ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Institut de Neuropsiquiatria i Addiccions   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Cannabis; CAST; DSM V; PRISM; Scale validation; SDS

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANNABIS ABUSE SCREENING TEST; CANNABIS ADDICTION; CLINICAL ASSESSMENT; CONSTRUCT VALIDITY; CRONBACH ALPHA COEFFICIENT; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PSYCHIATRIC INTERVIEW FOR SUBSTANCE AND MENTAL DISORDERS; PSYCHOMETRY; RATING SCALE; RELIABILITY; SCORING SYSTEM; SEVERITY OF DEPENDENCE SCALE; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; HUMANS; MARIJUANA ABUSE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84859946642     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2012.02.012     Document Type: Article

References (35)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) 1994, American Psychiatric Association, Washington, DC.
2. American Psychiatric Association DSM-V development 2011.
3. Batista-Foguet J.M., Coenders G., Alonso J. Análisis factorial confirmatorio. Su utilidad en la validación de cuestionarios relacionados con la salud. Medicina Clínica 2004, 122:21-27.
4. Bland J.M., Altman D.G. Cronbach's alpha. British Medical Journal 1997, 314:572.
5. Chassevent-Pajot A., Guillou-Landreat M., Grall-Bronnec M., Wainstein L., Philippe H.J., Lombrail P., et al. Epidemiological study on addictive behaviours during pregnancy in a universitary department. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction 2011, 40:237-245.
6. Drewe M., Drewe J., Riecher-Rossler A. Cannabis and risk of psychosis. Swiss Medical Weekly 2004, 134:659-663.
7. European Monitoring Centre for Drugs, Drug Addiction (EMCDDA) 2010 annual report on the state of the drugs problem in Europe 2010, Publications Office of the European Union, Lisbon.
8. Fabrigar L.R., Wegner D.T., MacCallum R.C., Strahan E.J. Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods 1999, 4:272-299.
9. Ferri C.P., Marsden J., de Araujo M., Laranjeira R.R., Gossop M. Validity and reliability of the Severity of Dependence Scale (SDS) in a Brazilian sample of drug users. Drug and Alcohol Review 2000, 19:451-455.
10. Gonzalez-Saiz F., de Las Cuevas C., Barrio G., Domingo-Salvany A. Spanish version of the Severity of Dependence Scale (SDS). Medicina Clínica 2008, 131:797-798.
11. Gonzalez-Saiz F., Domingo-Salvany A., Barrio G., Sanchez-Niubo A., Brugal M.T., de la Fuente L., et al. Severity of Dependence Scale as a diagnostic tool for heroin and cocaine dependence. European Addiction Research 2009, 15:87-93.
12. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., et al. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995, 90:607-614.
13. Gutiérrez-Rojas L., de Irala J., Martínez-González M.A. Efectos del cannabis sobre la salud mental en jóvenes consumidores. Revista de Medicina de la Universidad de Navarra 2006, 50:3-10.
14. Hasin D.S., Trautman K.D., Miele G.M., Samet S., Smith M., Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): Reliability for substance abusers. The American Journal of Psychiatry 1996, 153:1195-1201.
15. Hasin D., Samet S., Nunes E., Meydan J., Matseoane K., Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. The American Journal of Psychiatry 2006, 163:689-696.
16. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 2005, 330:11.
17. Kedzior K.K., Badcock J.C., Martin-Iverson M.T. Validity and consistency of self-reports regarding substance use in general research volunteers, including regular cannabis users and schizophrenia patients. Substance Use & Misuse 2006, 41:743-750.
18. Legleye S., Karila L., Beck F., Reynaud M. Validation of the CAST, a general population Cannabis Abuse Screening Test. Journal of Substance Use 2007, 12:233-242.
19. Legleye S., Piontek D., Kraus L. Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents. Drug and Alcohol Dependence 2010, 113:229-235.
20. Lynskey M., Hall W. The effects of adolescent cannabis use on educational attainment: A review. Addiction 2000, 95:1621-1630.
21. Lynskey M., Glowinski A.L., Todorov A. Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Archives of General Psychiatry 2004, 61:1026-1032.
22. Martin G., Copeland J., Gates P., Gilmour S. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-off. Drug and Alcohol Dependence 2006, 83:90-93.
23. Muthén B.O., Muthén L.K. Mplus (version 6.1) [computer software] 2010.
24. National Survey on Drug Use and Health.Substance Abuse and Mental Health Services Administration, Office of Applied Studies Results from the 2007 National Survey on Drug Use and Health: National findings (NSDUH Series H-34, DHHS Publication No.SMA08-4343). Rockville, MD 2008, available in, Rockville, MD. Last accessed on october 30, 2011. http://oas.samhsa.gov/nsduh/2k7nsduh/2k7results.cfm.
25. Observatorio Español de Drogas Informe 2007. Situación y tendencias de los problemas de drogas en España 2007, Ministerio del Interior, Madrid.
26. Observatorio Español de Drogas Informe 2009. Situación y tendencias de los problemas de drogas en España 2009, Ministerio de Sanidad y Política Social, Madrid.
27. Park H.S., Dailey R., Lemus D. The use of factor analysis and principal components in communication research. Human Communication Research 2002, 28:562-577.
28. Piontek D., Kraus L., Legleye S., Buhringer G. The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators. Addiction 2011, 106:1137-1145.
29. Solowij N., Stephens R.S., Roffman R.A. Cognitive functioning of long-term heavy cannabis users seeking treatment. Journal of the American Medical Association 2002, 287:1123-1131.
30. Stefanis C.N., Delespaul P., Henquet C. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004, 99:1333-1341.
31. Steiner S., Baumeister S.E., Kraus L. Severity of Dependence Scale: Establishing a cut-off point for cannabis dependence in the German adult population. Sucht 2008, 50:57-63.
32. Stinson F.S., Ruan W.J., Pickering R., Grant B.F. Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity. Psychological Medicine 2006, 36:1447-1460.
33. Swift W., Copeland J., Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998, 93:1681-1692.
34. Torrens M., Serrano D., Astals M., Perez-Dominguez G., Martin-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. The American Journal of Psychiatry 2004, 161:1231-1237.
35. United Nations Office on Drugs and Crime World drug report 2011 2011, Vienna.